Nana Yaa P. Sakyi Opoku, Arunima Mishra, Hansel Fletcher, Victor Nizet, Jacinda C. Abdul-Mutakabbir
下载PDF
{"title":"Enhancing Antimicrobial Susceptibility Testing for Acinetobacter baumannii Using Physiologically Relevant Culture Media and Biofilm Formation Assays","authors":"Nana Yaa P. Sakyi Opoku, Arunima Mishra, Hansel Fletcher, Victor Nizet, Jacinda C. Abdul-Mutakabbir","doi":"10.1002/cpz1.70207","DOIUrl":null,"url":null,"abstract":"<p><i>Acinetobacter baumannii</i> is a high-risk pathogen associated with increased patient morbidity and mortality. Host-pathogen interactions amplify its virulence, in part by promoting biofilm formation—a crucial factor in antimicrobial resistance and persistence. Given the bacterium's strong propensity for acquiring resistance, antimicrobial susceptibility testing (AST) is essential for guiding effective therapeutic interventions. However, discrepancies have been observed between <i>in vitro</i> AST results and therapeutic outcomes, with some antimicrobials being deemed to show <i>in vivo</i> efficacy despite appearing ineffective <i>in vitro</i>. This discordance may stem from traditional AST protocols, which rely on bacteriological media such as Mueller Hinton broth (MHB) optimized for bacterial growth but not for mimicking the host environment. Moreover, conventional AST does not account for virulence traits such as biofilm formation, which further contribute to treatment failure. Incorporating physiologically relevant culture media, such as Roswell Park Memorial Institute (RPMI) 1640 medium, alongside assessment of biofilm formation may improve the predictive value of AST. This work outlines two complementary protocols for improving AST interpretation in <i>A. baumannii</i> infections. Basic Protocol 1 compares minimum inhibitory concentration (MIC) values generated using MHB and RPMI. Basic Protocol 2 evaluates biofilm formation in MHB, tryptic soy broth (TSB; control), and RPMI, with and without antimicrobial exposure. Together, these approaches aim to inform alternative AST strategies that better reflect <i>in vivo</i> conditions and optimize therapeutic decision-making. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Comparing <i>A. baumannii</i> minimum inhibitory concentration (MIC) results in bacteriological (MHB) versus physiological (RPMI) media</p><p><b>Basic Protocol 2</b>: Comparing <i>A. baumannii</i> isolate(s) biofilm formation following assays completed in bacteriological culture media (MHB and control TSB) and physiological medium (RPMI)</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 9","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://currentprotocols.onlinelibrary.wiley.com/doi/epdf/10.1002/cpz1.70207","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current protocols","FirstCategoryId":"1085","ListUrlMain":"https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.70207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
Acinetobacter baumannii is a high-risk pathogen associated with increased patient morbidity and mortality. Host-pathogen interactions amplify its virulence, in part by promoting biofilm formation—a crucial factor in antimicrobial resistance and persistence. Given the bacterium's strong propensity for acquiring resistance, antimicrobial susceptibility testing (AST) is essential for guiding effective therapeutic interventions. However, discrepancies have been observed between in vitro AST results and therapeutic outcomes, with some antimicrobials being deemed to show in vivo efficacy despite appearing ineffective in vitro . This discordance may stem from traditional AST protocols, which rely on bacteriological media such as Mueller Hinton broth (MHB) optimized for bacterial growth but not for mimicking the host environment. Moreover, conventional AST does not account for virulence traits such as biofilm formation, which further contribute to treatment failure. Incorporating physiologically relevant culture media, such as Roswell Park Memorial Institute (RPMI) 1640 medium, alongside assessment of biofilm formation may improve the predictive value of AST. This work outlines two complementary protocols for improving AST interpretation in A. baumannii infections. Basic Protocol 1 compares minimum inhibitory concentration (MIC) values generated using MHB and RPMI. Basic Protocol 2 evaluates biofilm formation in MHB, tryptic soy broth (TSB; control), and RPMI, with and without antimicrobial exposure. Together, these approaches aim to inform alternative AST strategies that better reflect in vivo conditions and optimize therapeutic decision-making. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.
Basic Protocol 1 : Comparing A. baumannii minimum inhibitory concentration (MIC) results in bacteriological (MHB) versus physiological (RPMI) media
Basic Protocol 2 : Comparing A. baumannii isolate(s) biofilm formation following assays completed in bacteriological culture media (MHB and control TSB) and physiological medium (RPMI)
利用生理相关培养基和生物膜形成试验加强鲍曼不动杆菌的药敏试验
鲍曼不动杆菌是一种与患者发病率和死亡率增加相关的高风险病原体。宿主与病原体的相互作用增强了其毒力,部分原因是促进了生物膜的形成——这是抗菌素耐药性和持久性的关键因素。鉴于细菌获得耐药性的强烈倾向,抗菌药物敏感性试验(AST)对于指导有效的治疗干预至关重要。然而,已经观察到体外AST结果与治疗结果之间存在差异,一些抗菌素被认为在体内有效,尽管在体外无效。这种不一致可能源于传统的AST方案,它依赖于细菌培养基,如穆勒辛顿肉汤(MHB)优化细菌生长,但不模拟宿主环境。此外,传统的AST不能解释诸如生物膜形成等毒力特征,这进一步导致了治疗失败。结合与生理相关的培养基,如Roswell Park Memorial Institute (RPMI) 1640培养基,以及生物膜形成的评估,可能会提高AST的预测价值。这项工作概述了两种互补的方案,以提高鲍曼不动杆菌感染中AST的解释。基本方案1比较了MHB和RPMI产生的最小抑制浓度(MIC)值。基本方案2评估MHB、胰蛋白酶肉汤(TSB;对照)和RPMI在接触和不接触抗菌药物时的生物膜形成情况。总之,这些方法旨在为更好地反映体内条件和优化治疗决策的替代AST策略提供信息。©2025作者。基本方案1:比较鲍曼不动杆菌在细菌学(MHB)和生理(RPMI)培养基中的最低抑制浓度(MIC)结果。基本方案2:比较鲍曼不动杆菌分离物在细菌学培养基(MHB和对照TSB)和生理培养基(RPMI)中完成的生物膜形成试验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。